Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• Isotechnika Reports Final Results of the PROMISE Trial
• Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer
• Isotechnika to Hold Conference Call to Discuss Positive PROMISE Trial
• Isotechnika Presents Positive Data From the Promise Trial of Voclosporin at the American Transplant Congress
• Movetis Presents New Data at Digestive Disease Week
• Movetis Files RESOLOR(R) With EMEA for the Indication of Chronic Constipation
• Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
• Targeted Genetics gibt positive Phase-1/2-Ergebnisse zu tgAAC94 auf dem europäischen Rheumatologiekongress EULAR bekannt
• Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
• Data Suggests Promising Overall Survival and Progression-Free Survival With VARGATEF(TM) (BIBF 1120)

ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

ots.at: das APA-OTS-Portal f�r multimediale Presseaussendungen.Presse Movetis' Second Most Advanced Product Progresses to Phase IIb Trial

Presseportal: Meldung versenden

Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites E-Mail-Adresse des Empfängers: Sie

MedCrawler.de - Die Suchmaschine für Medizin und Gesundheit

Call to Discuss Positive PROMISE Trial Movetis' Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites

www.ad-hoc-news.de/sitemap49.xml

http://www.ad-hoc-news.de/Handelssignale/18070756/Results+second+quarter+20 08 signale/18083293/Western+Union+to+Release+Second+Quarter+Results+on+July+22 %2C+2008

NEWS :: MOVETIS SECOND MOST ADVANCED PRODUCT PROGRESSES TO PHASE IIB ...

Movetis Second Most Advanced Product Progresses to Phase IIb Trial Following Positive Results in Cirrhotic Ascites Aktuelle Nachrichten - Turnhout, Belgium (ots